Editorial: Design considerations in migraine with aura trials: Learning from experience

Cephalalgia

Volumn 30, Issue 9, 2010, Pages 1027-1028

  Loder, Elizabeth ^a  

^a Brigham and Women's/Faulkner Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TONABERSAT; BENZAMIDE DERIVATIVE; BENZOPYRAN DERIVATIVE;

BLURRED VISION; BRAIN ISCHEMIA; CLINICAL TRIAL; EDITORIAL; HEADACHE; HUMAN; MIGRAINE WITH AURA; ANIMAL; CLINICAL TRIAL (TOPIC); METHODOLOGY; NOTE;

ANIMALS; BENZAMIDES; BENZOPYRANS; CLINICAL TRIALS AS TOPIC; HUMANS; MIGRAINE WITH AURA;

EID: 78449285315     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410368441     Document Type: Editorial

References (7)

1. Hauge A., Hougaard A., Olesen J. On the methodology of drug trials in migraine with aura. Cephalalgia 2010.
2. Eriksen MK, Thomsen LL, Olesen J. The Visual Aura Rating Scale (VARS) for migraine aura diagnosis. Cephalalgia 2005 ; 25: 801-810.
3. Mattson P., Lundberg PO Characteristics and prevalence of transient visual disturbances indicative of migraine visual aura. Cephalalgia 1999 ; 19: 479-484.
4. MacClellan LR, Giles W., Cole J., et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007 ; 38: 2438-2445.
5. Kurth T., Schuerks M., Logroscino T., Buring JE Migraine frequency and risk of cardiovascular disease in women. Neurology 2009 ; 73: 581-588.
6. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2 nd edition. Cephalalgia 2004 ; 24 (Suppl 1). 1-160.
7. Tfelt-Hansen P., Block G., Dahlof D., et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000 ; 20: 765-786.